Skip to Content
Merck
  • Genome-Wide Screen and Validation of Microglia Pro-Inflammatory Mediators in Stroke.

Genome-Wide Screen and Validation of Microglia Pro-Inflammatory Mediators in Stroke.

Aging and disease (2021-06-08)
Jianhua Wu, Zhuoze Wu, Aodi He, Tongmei Zhang, Ping Zhang, Jing Jin, Sisi Li, Gaigai Li, Xinyan Li, Shiqi Liang, Lei Pei, Rong Liu, Qing Tian, Ximiao He, Youming Lu, Zhouping Tang, Hao Li
ABSTRACT

Stroke activates microglia pro-inflammatory response that not only induces the early neuronal injuries but also causes the secondary brain infarction. Yet, the underlying mechanisms for how microglia become activated in stroke are still unknown. Here, using the next-generation of RNA sequencing we find a total of 778 genes increasingly expressed in brain of stroke mice. Of these, we identified Hmgb2 as a microglia pro-inflammatory mediator by promoting the transcription of Ctss. Inhibition of either Hmgb2 or Ctss blocks microglia pro-inflammatory response and protects against brain damages and improves the neurological functions of stroke mice. This study uncovers Hmgb2 and Ctss as the major microglia inflammatory response mediators in stroke and hence warrants the promising targets for stroke therapies.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Trichloroacetic acid solution, 6.1 N